Securities and Exchange Commission (SEC) news and information

Health Management Associates, Naples, Fla., is facing a subpoena from the Securities and Exchange Commission, potentially related to its billing and accounting practices.
FULL STORY »

Hospira successfully fought off a government request for more details about its prolonged efforts to fix safety problems, a win that highlights the scrutiny of CEO F. Michael Ball's efforts to boost production at the giant medical products maker.
FULL STORY »

The Securities and Exchange Commission charged a GlaxoSmithKline subsidiary and its former chairman and CEO (PDF) with buying back stock at undervalued prices and defrauding employees and other shareholders.
FULL STORY »

CEOs at publicly traded healthcare providers have a big personal incentive to try to engineer a rebound in their companies' share prices: CEO personal holdings at their respective companies are down more than $180 million in value this year.
FULL STORY »

For tax-exempt hospitals, one primary source of capital is an increasing source of uncertainty.
FULL STORY »

Select Medical Holdings Corp., which operates 81 specialty and long-term acute-care hospitals in states across the country, has agreed to settle fraud allegations and enter a corporate integrity agreement. HHS' inspector general's office published the five-year integrity agreement, while records on...
FULL STORY »

As hospitals wait for a final definition of municipal advisers, the Municipal Securities Rulemaking Board continues to press on with the release of new adviser oversight.
FULL STORY »

Though little-noticed in the wider world, the U.S. Justice Department's ongoing investigation into one of the most lucrative medical devices on the market has delivered a strong jolt to heart hospitals and cardiac physicians across the country.
FULL STORY »

Mired in a long-running financial morass threatening its existence, Jackson Health System last week bypassed two experienced healthcare executives and chose a banker with deep Miami roots to become the next CEO of the 1,765-bed public health system.
FULL STORY »

Johnson & Johnson agreed to pay more than $70 million to settle allegations that the company bribed doctors in Greece, Poland and Romania and paid kickbacks to Iraq to win contracts. The New Brunswick, N.J.-based healthcare company agreed to pay $48.6 million in disgorgement and prejudgment...
FULL STORY »